Core Viewpoint - Guizhou Xintian Pharmaceutical Co., Ltd.'s wholly-owned subsidiary, Shanghai Shuo Fang Pharmaceutical Technology Co., Ltd., has received a patent for a method to detect the fingerprint spectrum of ginkgo biloba decoction, which will enhance the company's intellectual property protection and core competitiveness [1] Summary by Relevant Categories Patent Information - The patent certificate (No. 8210031) was issued by the National Intellectual Property Administration, with the application date on June 19, 2023, and the authorization announcement date set for August 29, 2025 [1] Product Quality Assurance - The patented method allows for comprehensive detection of the chemical components of ginkgo biloba, providing a basis for ensuring product quality, which will be utilized in the production of related new drugs [1] Impact on Company Operations - While the patent does not have a significant immediate impact on the company's production and operations, it contributes positively to the enhancement of the intellectual property protection system [1]